博济医药

- 300404

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
博济医药(300404) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入55,614.8834,139.0816,742.4455,583.2435,878.27
营业收入55,614.8834,139.0816,742.4455,583.2435,878.27
二、营业总成本51,993.7531,814.2614,832.9853,855.5434,636.63
营业成本37,714.0123,005.7311,077.7937,054.0822,945.21
营业税金及附加530.52337.96117.76447.74337.80
销售费用3,872.762,345.691,092.184,198.403,082.42
管理费用5,341.843,400.351,462.616,700.704,669.33
财务费用89.5742.45-51.50-42.42-52.19
研发费用4,445.062,682.091,134.135,497.043,654.06
资产减值损失----------
公允价值变动收益98.0655.4646.0358.9954.22
投资收益148.20137.8156.91219.5099.03
其中:对联营企业和合营企业的投资收益-5.81-4.17-2.22-12.75-9.11
汇兑收益----------
三、营业利润3,122.411,947.121,661.451,763.901,702.21
加:营业外收入4.504.494.423.0913.87
减:营业外支出10.594.532.704.023.41
其中:非流动资产处置损失----------
四、利润总额3,116.321,947.081,663.171,762.981,712.67
减:所得税费用-1,419.85-1,141.44-62.50-956.29-772.05
五、净利润4,536.183,088.531,725.672,719.272,484.72
归属于母公司所有者的净利润4,327.783,013.511,651.312,433.942,302.26
少数股东损益208.4075.0174.36285.33182.46
六、每股收益
基本每股收益(元/股)0.11330.07890.04320.06570.0624
稀释每股收益(元/股)0.11310.07880.04320.06570.0623
七、其他综合收益-36.9513.6056.4566.79112.35
八、综合收益总额4,499.233,102.131,782.122,786.062,597.06
归属于母公司所有者的综合收益总额4,291.233,026.811,707.672,495.912,408.99
归属于少数股东的综合收益总额208.0075.3374.45290.15188.07
下载全部历史数据到excel中 返回页顶